Status:
ACTIVE_NOT_RECRUITING
Rheumatic Heart Disease Research and Screening in Nepal: A Feasibility Study
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Fogarty International Center of the National Institute of Health
Conditions:
Rheumatic Heart Disease
Eligibility:
All Genders
Brief Summary
Rheumatic Heart Disease (RHD) remains a significant public health problem in lower and middle-income countries, accounting for over 300,000 deaths world-wide. RHD is a sequela of Acute Rheumatic Fever...
Eligibility Criteria
Inclusion
- RHD patients
Exclusion
- \-
Key Trial Info
Start Date :
August 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2040
Estimated Enrollment :
2438 Patients enrolled
Trial Details
Trial ID
NCT05250154
Start Date
August 27 2018
End Date
May 1 2040
Last Update
June 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhulikhel Hospital
Dhulikhel, Kavre, Nepal